Bias prevention in biological design algorithms

Introduction

Bias prevention in biological design algorithms refers to the development and implementation of technical, ethical, and legal measures to prevent discriminatory, inaccurate, or systematically unfair outcomes generated by computational systems used in biological research and biotechnology.

Biological design algorithms are computational tools used to design, analyse, and optimise biological systems. They are increasingly applied in synthetic biology, genetic engineering, protein engineering, drug discovery, genome editing, metabolic engineering, and the development of artificial biological organisms.

These algorithms use biological datasets, mathematical models, machine learning, and artificial intelligence to predict biological behaviour and identify suitable designs for research and industrial applications.

However, algorithms may produce biased results when their training datasets are incomplete, unrepresentative, or scientifically inaccurate. Bias may also arise from the assumptions used by researchers, the selection of biological parameters, and the objectives established during algorithm development.

For example, an algorithm designed to predict genetic variations may perform accurately for populations represented extensively in its training dataset but generate unreliable predictions for underrepresented populations. Similarly, a protein-design algorithm may favour certain experimentally studied protein structures because its training data contains insufficient information about alternative biological structures.

Bias prevention is therefore necessary to ensure scientific accuracy, equal treatment, responsible innovation, and the ethical application of biotechnology.

Meaning and types of bias in biological design algorithms

Bias in biological design algorithms refers to systematic distortions in computational processes that influence the selection, prediction, optimisation, or evaluation of biological designs.

The major forms of bias include:

1. Dataset bias

Dataset bias occurs when biological information used to train an algorithm does not adequately represent biological diversity.

For example, a genomic design algorithm trained primarily on European genetic datasets may produce less reliable predictions for South Asian or African populations.

2. Population bias

Population bias arises when algorithms are developed using biological characteristics from limited population groups.

This may affect the accuracy of genetic testing, disease prediction, and personalised medicine.

3. Algorithmic bias

Algorithmic bias occurs when the mathematical structure or computational logic of a system produces systematically unequal results.

It may result from inappropriate optimisation objectives, flawed assumptions, or limitations in machine-learning architecture.

4. Experimental bias

Experimental bias occurs when the biological experiments used to validate an algorithm are conducted under restricted laboratory conditions.

Consequently, an algorithm may perform well in controlled laboratory environments but fail when applied to different biological systems.

5. Selection bias

Selection bias occurs when researchers preferentially include certain biological samples, genetic sequences, or protein structures while excluding others.

This may distort the conclusions produced by biological design systems.

6. Objective-function bias

Objective-function bias occurs when the criteria used to optimise a biological design favour certain outcomes while ignoring other important considerations.

For example, a protein-design algorithm that prioritises stability without adequately considering toxicity or biological compatibility may produce unsuitable results.

Importance of bias prevention in biological design

Bias prevention is essential because biological design algorithms can influence scientific research, medical treatments, pharmaceutical development, and environmental applications.

Its major objectives include:

Scientific reliability: Ensuring that algorithmic predictions are based on accurate and representative biological information.

Population inclusiveness: Preventing the exclusion of underrepresented genetic and biological populations.

Patient safety: Reducing errors in computational systems used for drug development and personalised medicine.

Non-discrimination: Preventing unfair outcomes arising from genetic or biological classifications.

Research transparency: Ensuring that algorithmic assumptions and limitations are properly documented.

Reproducibility: Supporting independent verification of computational research findings.

Responsible innovation: Ensuring that biological design technologies are developed according to appropriate scientific and ethical standards.

International legal and regulatory framework

1. UNESCO Universal Declaration on the Human Genome and Human Rights, 1997

This declaration establishes important international principles concerning genetic equality, human dignity, and protection against discrimination.

Article 2 recognises the importance of respecting human dignity and individual rights regardless of genetic characteristics.

Article 6 addresses discrimination based on genetic characteristics.

These provisions are relevant to biological design algorithms that use human genetic information for medical research, genetic classification, and personalised treatment development.

2. UNESCO International Declaration on Human Genetic Data, 2003

This declaration provides principles concerning the collection, processing, storage, and use of human genetic information.

It emphasises informed consent, confidentiality, privacy, and protection against discrimination.

Biological design algorithms that process genetic datasets should therefore incorporate appropriate safeguards to prevent misuse and unfair treatment.

3. European Union Artificial Intelligence Act, 2024

The EU Artificial Intelligence Act establishes a risk-based regulatory framework for AI systems.

It introduces requirements relating to risk management, data governance, technical documentation, transparency, accuracy, and human oversight for relevant high-risk AI systems.

AI systems used in medical devices and other regulated healthcare applications may fall within its high-risk framework depending on their intended purpose and applicable classification.

These requirements are relevant when AI-based biological design algorithms are incorporated into regulated medical or biotechnology products.

4. General Data Protection Regulation, 2016

The GDPR provides safeguards for personal data, including genetic and health information.

Article 5 establishes principles of fairness, transparency, and accuracy.

Article 9 provides additional protections for genetic and health data.

These requirements are important when biological design algorithms use identifiable human genetic information.

5. Convention on Biological Diversity, 1992

The Convention on Biological Diversity establishes principles concerning biodiversity conservation, sustainable utilisation, and equitable benefit sharing.

Articles 8(j) and 15 are particularly relevant to traditional knowledge and access to genetic resources.

Biological design algorithms that utilise genetic resources or associated traditional knowledge should be developed with due regard to applicable access, consent, and benefit-sharing obligations.

Indian legal and regulatory framework

India has several legal and ethical instruments relevant to preventing bias in biological design algorithms.

1. Constitution of India

Article 14 guarantees equality before the law and equal protection of the laws.

Article 15 prohibits specified forms of discrimination by the State.

Article 21 protects life and personal liberty, including privacy and human dignity.

These constitutional principles provide a foundation for preventing discriminatory uses of genetic information and computational technologies.

2. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 regulates the processing of digital personal data within its scope.

Where biological design algorithms process identifiable genetic or health information, applicable requirements concerning lawful processing, consent, security, and individual rights must be considered.

The Act does not independently establish a comprehensive technical framework for algorithmic bias prevention.

3. ICMR National Ethical Guidelines, 2017

The Indian Council of Medical Research guidelines establish ethical standards for biomedical and health research involving human participants.

They address informed consent, confidentiality, scientific validity, participant protection, and ethical review.

These guidelines are relevant when biological design algorithms use human samples, genomic information, or clinical research datasets.

4. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources and associated traditional knowledge.

Its framework is relevant when biological design algorithms utilise biological materials obtained from Indian biodiversity.

The Act also provides for equitable benefit sharing in applicable circumstances.

Therefore, organisations developing biological algorithms using biological resources must consider relevant access and benefit-sharing obligations.

Methods of preventing bias in biological design algorithms

Bias prevention requires a combination of scientific validation, algorithmic testing, ethical governance, and legal compliance.

1. Development of representative datasets

Researchers should use diverse and scientifically appropriate biological datasets.

Genomic databases should include relevant ancestral and geographical diversity to reduce population-related inaccuracies.

2. Data quality assessment

Biological information should be examined for missing values, measurement errors, inconsistencies, and historical distortions.

Poor-quality data can negatively affect algorithmic predictions.

3. Algorithmic fairness testing

Researchers should evaluate whether algorithms produce significantly different error rates or unreliable predictions across relevant population groups.

Testing should consider the intended biological application rather than relying on a single universal fairness measure.

4. Independent scientific validation

Biological design algorithms should be tested using independent experimental datasets and laboratory observations.

This helps establish whether predicted biological outcomes are scientifically reliable.

5. Transparent model documentation

Researchers should maintain documentation describing training datasets, design objectives, mathematical assumptions, limitations, and validation procedures.

6. Human supervision

Qualified scientists, genetic researchers, and medical professionals should review important algorithmic outputs before their application in sensitive research or healthcare settings.

7. Continuous monitoring

Algorithms should be regularly reassessed as new biological information becomes available.

Changes in datasets, experimental conditions, and scientific understanding may introduce new forms of bias.

Important judicial decisions and case laws

The following judgments establish relevant principles concerning equality, privacy, discrimination, intellectual property, and technological accountability. Most are not direct biological algorithm bias cases but provide legal principles applicable to the subject.

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court of India recognised privacy as a fundamental right under Article 21 and other constitutional guarantees.

The judgment recognised informational privacy and individual autonomy, emphasising that personal information must be protected against unjustified interference.

Legal significance: Biological design algorithms may process genetic information capable of revealing inherited characteristics and disease susceptibility. The judgment provides an important constitutional foundation for protecting genomic information and preventing its inappropriate use.

2. National Legal Services Authority v. Union of India (2014)

The Supreme Court of India recognised the constitutional rights of transgender persons and emphasised equality, dignity, and protection against discrimination.

The Court highlighted that individuals must receive equal constitutional protection regardless of gender identity.

Legal significance: The judgment supports the principle that computational systems should not rely on discriminatory classifications or assumptions. It is relevant to biological algorithms that classify or analyse human characteristics.

3. Navtej Singh Johar v. Union of India (2018)

The Supreme Court examined constitutional protections relating to equality, dignity, autonomy, and individual identity.

The judgment reinforced the importance of protecting individuals from discriminatory treatment.

Legal significance: Its constitutional principles are relevant when biological design systems use human characteristics or genetic information in ways that could result in unfair classification or exclusion.

4. Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)

The United States Supreme Court considered whether naturally occurring human DNA sequences could be patented.

The Court held that naturally occurring DNA is not patentable merely because it has been isolated from the human body. However, appropriately created cDNA may qualify for patent protection.

Legal significance: The decision is relevant to biological design algorithms because it clarifies the distinction between naturally occurring biological material and human-created technological innovations. It also raises important questions concerning access to genetic information and the commercialisation of biotechnology discoveries.

5. Diamond v. Chakrabarty (1980)

The United States Supreme Court examined whether a genetically engineered microorganism could qualify as patentable subject matter.

The Court held that a genetically engineered microorganism with markedly different characteristics could qualify for patent protection under the applicable US patent law.

Legal significance: The decision is important in biotechnology because it addresses the legal treatment of engineered biological inventions. It provides context for regulating innovation in computational biological design while maintaining appropriate ethical and legal safeguards.

6. R (Bridges) v. Chief Constable of South Wales Police (2020)

The Court of Appeal of England and Wales examined the use of automated facial recognition technology by police authorities.

The Court identified deficiencies concerning the legal framework, data protection, and equality considerations associated with the technology.

Legal significance: Although the case involved facial recognition rather than biological design, it demonstrates the importance of assessing potential discriminatory effects, maintaining accountability, and ensuring that automated technological systems operate within legal boundaries.

Challenges in preventing bias

Several practical and legal challenges affect the prevention of bias in biological design algorithms.

Limited biological datasets: Researchers may lack sufficient information about different populations and biological systems.

Scientific complexity: Biological processes involve complex interactions that cannot always be accurately represented through computational models.

Lack of transparency: Proprietary algorithms may restrict independent examination of their design and assumptions.

Historical inequalities: Existing scientific datasets may reflect unequal research participation.

Commercial pressures: Organisations may prioritise development speed and profitability over extensive fairness testing.

Regulatory uncertainty: Different jurisdictions apply different requirements to AI, biotechnology, genetic information, and biological research.

Validation difficulties: Some algorithmic predictions may be difficult or expensive to verify through laboratory experiments.

Conclusion

Bias prevention in biological design algorithms is an essential component of responsible biotechnology governance. As computational technologies become increasingly important in genetic engineering, synthetic biology, protein design, pharmaceutical development, and personalised medicine, preventing systematic errors and discriminatory outcomes becomes necessary.

International frameworks such as the UNESCO declarations on the human genome and genetic data, the GDPR, the EU Artificial Intelligence Act, and the Convention on Biological Diversity provide important principles for responsible biological research.

In India, constitutional guarantees under Articles 14, 15, and 21, the Digital Personal Data Protection Act, 2023, the ICMR ethical guidelines, and the Biological Diversity Act, 2002 provide relevant legal and ethical safeguards.

Judicial decisions such as Justice K.S. Puttaswamy v. Union of India (2017), National Legal Services Authority v. Union of India (2014), Association for Molecular Pathology v. Myriad Genetics (2013), and Diamond v. Chakrabarty (1980) offer important principles concerning privacy, equality, biological innovation, and legal accountability.

Ultimately, effective bias prevention requires representative biological datasets, transparent algorithms, independent validation, ethical oversight, and continuous monitoring. These measures help ensure that biological design technologies remain scientifically reliable, legally accountable, and socially beneficial.